Small-Cap Stocks Set to Resume Their Rally

Comments (1)

  1. Mark says:

    I follow InVivo (NVIV), a Small Cap Biotech that has 3 of 3 spinal cord injury patients doing excellent after a scaffold was implanted in their spinal cord. I doubt this company has any concerns whatsoever about Greece, even though they are supposedly preparing to apply for the CE Mark to market in the EU. Who needs Greece?

    Thanks for some sensible analysis.


Add Comment